Cellectis S.A. American Depositary Shares (CLLS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cellectis S.A. American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Cellectis S.A. American Depositary Shares (CLLS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $106M. It trades at $1.26, up 20.00% today. Its overall quality score is 52 out of 100, ranked against the whole US market. 4 analysts' average target of $4.10 implies +225.4% from today's price. Kronos AI's 30-day forecast is +159.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.10 |
| Low – high | $1.30 – $8.00 |
| Analysts | 4 |
| Upside to average | +225.4% |
Kronos AI 30-day forecast
| Expected close | $2.73 (+159.8%) |
| Likely range | +119.0% … +234.8% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 41 |
| Solvency | 61 |
| Growth | 54 |
| Overall | 52 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator